You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameCamphor
Accession NumberDB01744  (EXPT00827)
TypeSmall Molecule
GroupsExperimental
Description

A bicyclic monoterpene ketone found widely in plants, especially cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. [PubChem]

Structure
Thumb
SynonymsNot Available
Prescription ProductsNot Available
Generic Prescription ProductsNot Available
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Vaporizinginhalant62 mg/mLrespiratory (inhalation)Walgreen Co2009-06-01Not AvailableUs
Walgreens Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalWalgreens2013-04-05Not AvailableUs
Walgreens Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalWalgreens2013-07-15Not AvailableUs
Painzaway Balmointment4 g/100gtopicalIndiana Botanic Gardens2001-12-01Not AvailableUs
Neuro Support Plus Foot Balmointment4 g/100gtopicalIndiana Botanic Gardens2014-06-26Not AvailableUs
Rite Aid Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalRite Aid2013-04-05Not AvailableUs
Jointflexcream3.58 g/114gtopicalMOBERG PHARMA NORTH AMERICA LLC2010-04-16Not AvailableUs
Safeway Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalSafeway2013-04-10Not AvailableUs
De La Cruz Camphorointment11 g/100gtopicalDLC Laboratories, Inc.2012-07-26Not AvailableUs
Earths Care Arnica Compoundointment3 g/100gtopicalDLC Laboratories, Inc.2012-02-22Not AvailableUs
Kroger Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalThe Kroger Co.2013-04-30Not AvailableUs
Topcare Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalTopco Associates LLC2013-04-10Not AvailableUs
Shopko Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalShop Ko Stores Operating Co., Llc2013-04-16Not AvailableUs
Vaproizingliquid62 mg/mLrespiratory (inhalation)H E B2010-10-06Not AvailableUs
Equaline Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalSupervalu Inc2013-04-12Not AvailableUs
Vaporizingliquid62 mg/mLrespiratory (inhalation)Meijer Distribution Inc2011-07-22Not AvailableUs
Meijer Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalMeijer2013-04-05Not AvailableUs
Careone Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalAmerican Sales Company2013-04-17Not AvailableUs
Inflammation Otc Bruise Relieflotion32 g/1000gtopicalSkin Deep2011-08-08Not AvailableUs
Vaporizinginhalant62 mg/mLrespiratory (inhalation)Wal Mart Stores, Inc2014-03-07Not AvailableUs
Sierrasil Pain Reliefspray1 mL/30mLtopicalSierra Mountain Minerals Inc. d/b/a Sierra Sil Health Inc.2010-03-01Not AvailableUs
Flex24 Pain Penliquid7.79 g/100mLtopicalLarasan Pharmaceutical Corporation2015-02-10Not AvailableUs
Flex24 Performance Penliquid7.79 g/100mLtopicalLarasan Pharmaceutical Corporation2014-04-08Not AvailableUs
Western Family Pain Relievingcream.04; .1; .3 g/g; g/g; g/gtopicalWestern Family Food, Inc.2013-06-30Not AvailableUs
Western Family Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalWestern Family Foods Inc2013-04-10Not AvailableUs
Healthy Accents Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalDZA Brands LLC2013-04-30Not AvailableUs
O24 Pain Neutralizerspray3.1 g/100mLtopicalO24 Naturals LLC2007-12-03Not AvailableUs
Sierrasil Pain Reliefspray3.1 g/100mLtopicalO24 Naturals, LLC2013-02-01Not AvailableUs
Camphorliquid155 mg/mLrespiratory (inhalation)CVS2009-05-19Not AvailableUs
Apanol Alcanforointment10 g/100gtopicalDelon Laboratories (1990) Ltd2010-11-19Not AvailableUs
Best Choice Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalBest Choice2013-05-02Not AvailableUs
Abridge Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalRanir LLC2013-04-05Not AvailableUs
Joint Formula 88 Max Pluscream3.18 g/100gtopicalSarati International, Inc.2013-08-01Not AvailableUs
Premier Value Cold Sore Treatmentcream1.3; 30 mg/g; mg/gtopicalPremier Value2013-04-16Not AvailableUs
Blue Starointment12.4 mg/gtopicalGHC Group, LLC2012-10-30Not AvailableUs
Tapout Muscle Recovery Rapid Pain Reliefspray1 mL/30mLtopicalRevive Bioscience, Inc.2012-02-01Not AvailableUs
Tapout Muscle Recoverycloth1 mLtopicalRevive Bioscience, Inc.2012-02-01Not AvailableUs
O24 Essential Oil Pain Relievingspray1 mL/30mLtopicalRevive Bioscience, Inc.2012-02-01Not AvailableUs
O24 Essential Oil Pain Relievingcloth1 mLtopicalRevive Bioscience, Inc.2012-02-01Not AvailableUs
Maxrelief Arnicacream30 mg/1000mgtopicalNatures Investment Holdings Pty Ltd dba Maxrelief USA2014-06-01Not AvailableUs
International BrandsNot Available
Brand mixturesNot Available
SaltsNot Available
CategoriesNot Available
CAS number76-22-2
WeightAverage: 152.2334
Monoisotopic: 152.120115134
Chemical FormulaC10H16O
InChI KeyDSSYKIVIOFKYAU-OIBJUYFYSA-N
InChI
InChI=1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3/t7-,10+/m0/s1
IUPAC Name
(1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
SMILES
CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
Mass SpecNot Available
Taxonomy
KingdomOrganic Compounds
SuperclassLipids
ClassPrenol Lipids
SubclassMonoterpenes
Direct parentBicyclic Monoterpenes
Alternative parentsCyclohexanones; Polyamines
Substituentscyclohexanone; ketone; polyamine; carbonyl group
Classification descriptionThis compound belongs to the bicyclic monoterpenes. These are monoterpenes containing exactly 2 rings, which are fused to each other.
Pharmacology
IndicationNot Available
PharmacodynamicsNot Available
Mechanism of actionNot Available
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
Metabolism
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityNot Available
Affected organismsNot Available
PathwaysNot Available
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
Property Value Probability
Human Intestinal Absorption + 0.9971
Blood Brain Barrier + 0.9836
Caco-2 permeable + 0.8084
P-glycoprotein substrate Non-substrate 0.5868
P-glycoprotein inhibitor I Non-inhibitor 0.639
P-glycoprotein inhibitor II Non-inhibitor 0.9104
Renal organic cation transporter Non-inhibitor 0.8103
CYP450 2C9 substrate Non-substrate 0.823
CYP450 2D6 substrate Non-substrate 0.8379
CYP450 3A4 substrate Substrate 0.6692
CYP450 1A2 substrate Non-inhibitor 0.8876
CYP450 2C9 substrate Non-inhibitor 0.9088
CYP450 2D6 substrate Non-inhibitor 0.9696
CYP450 2C19 substrate Non-inhibitor 0.9313
CYP450 3A4 substrate Non-inhibitor 0.9583
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.978
Ames test Non AMES toxic 0.9133
Carcinogenicity Non-carcinogens 0.8235
Biodegradation Not ready biodegradable 0.6872
Rat acute toxicity 1.6328 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.913
hERG inhibition (predictor II) Non-inhibitor 0.8076
Pharmacoeconomics
ManufacturersNot Available
Packagers
Dosage forms
FormRouteStrength
Clothtopical1 mL
Creamtopical.04; .1; .3 g/g; g/g; g/g
Creamtopical1.3; 30 mg/g; mg/g
Creamtopical3.18 g/100g
Creamtopical3.58 g/114g
Creamtopical30 mg/1000mg
Inhalantrespiratory (inhalation)62 mg/mL
Liquidrespiratory (inhalation)155 mg/mL
Liquidrespiratory (inhalation)62 mg/mL
Liquidtopical7.79 g/100mL
Lotiontopical32 g/1000g
Ointmenttopical10 g/100g
Ointmenttopical11 g/100g
Ointmenttopical12.4 mg/g
Ointmenttopical3 g/100g
Ointmenttopical4 g/100g
Spraytopical1 mL/30mL
Spraytopical3.1 g/100mL
PricesNot Available
PatentsNot Available
Properties
Statesolid
Experimental Properties
PropertyValueSource
melting point180 °CPhysProp
boiling point204 °CPhysProp
water solubility1600 mg/L (at 25 °C)YALKOWSKY,SH & HE,Y (2003)
logP2.38DAYLIGHT (1999)
Predicted Properties
PropertyValueSource
Water Solubility0.88ALOGPS
logP2.85ALOGPS
logP2.55ChemAxon
logS-2.2ALOGPS
pKa (Strongest Basic)-7.5ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area17.07 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity44.49 m3·mol-1ChemAxon
Polarizability17.73 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
SpectraNot Available
References
Synthesis Reference

Gerard Lang, Serge Forestier, Alain LaGrange, “Derivatives of 3-benzylidene camphor, process for their preparation and their use as protective agents against UV rays and as medicaments.” U.S. Patent US4710584, issued January, 1984.

US4710584
General ReferenceNot Available
External Links
ResourceLink
KEGG DrugD00098
KEGG CompoundC00808
PubChem Compound444294
PubChem Substance46508429
ChemSpider2441
ChEBI36773
ChEMBL
PharmGKBPA448759
HETCAM
Drugs.comhttp://www.drugs.com/cdi/camphor-liquid.html
WikipediaCamphor
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSNot Available
Interactions
Drug InteractionsNot Available
Food InteractionsNot Available

Targets

1. Camphor 5-monooxygenase

Kind: protein

Organism: Pseudomonas putida

Pharmacological action: unknown

Components

Name UniProt ID Details
Camphor 5-monooxygenase P00183 Details

References:

  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed

Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:15